Literature DB >> 9148865

Diagnosis of primary liver cancer using lectin affinity chromatography of serum alkaline phosphatase.

Y Lu1, Q Lu, H L Chen.   

Abstract

Serum alkaline phosphatase (sALP) can be separated into unbound liver type (L-ALP) and bound bone type (B-ALP) by means of WGA affinity chromatography. The L-ALP from the sera of normal adults and various liver diseases was found to show different chromatographic behaviours on DSA affinity column with multiple peaks of ALP activity after the L-ALP was treated with neuraminidase to remove the terminal sialic acids on the sugar chain of L-ALP. The L-ALP from normal sera contained no bound activity on DSA, whereas that from acute or chronic hepatisis, liver cirrhosis and biliary obstruction had a significant amount of bound fractions with weak and intermediate affinity. The strongly bound fraction(s) was only present in the L-ALP serum from primary liver cancer (PLC) and the positive rate of its appearance was 100% in 38 cases of PLC, including 8 alpha-fetoprotein (AFP) negative cases. The WGA chromatography can be skipped and similar results are obtained. The percentage of the strongly bound fraction in serum L-ALP was not related to the level of either sALP activity or AFP, and the appearance of the strongly bound fraction is attributed to the structural difference of sugar chains in L-ALP. Therefore, this L-ALP fraction may be assumed as a new index in the diagnosis of PLC, and the different profiles of sALP or L-ALP on DSA chromatography may be used in the differential diagnosis of benign and malignant liver diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9148865

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  7 in total

1.  Identification of N-glycan of alpha-fetoprotein by lectin affinity microarray.

Authors:  Pei Chen; YinKun Liu; XiaoNan Kang; Lu Sun; PengYuan Yang; ZhaoYou Tang
Journal:  J Cancer Res Clin Oncol       Date:  2008-02-09       Impact factor: 4.553

2.  Serum alkaline phosphatase predicts survival outcomes in patients with skeletal metastatic nasopharyngeal carcinoma.

Authors:  Ying Jin; Mei-Qin Yuan; Jun-Qing Chen; Yi-Ping Zhang
Journal:  Clinics (Sao Paulo)       Date:  2015-04       Impact factor: 2.365

3.  Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma.

Authors:  Lin Yang; Liangping Xia; Yan Wang; Shasha He; Haiyang Chen; Shaobo Liang; Peijian Peng; Shaodong Hong; Yong Chen
Journal:  BMC Cancer       Date:  2017-09-06       Impact factor: 4.430

4.  Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index of Overall Survival in Cisplatin-based Chemotherapy-treated Patients with Metastatic Nasopharyngeal Carcinoma.

Authors:  Man Nie; Peng Sun; Cui Chen; Xiwen Bi; Yu Wang; Hang Yang; Panpan Liu; Zhiming Li; Yi Xia; Wenqi Jiang
Journal:  J Cancer       Date:  2017-02-25       Impact factor: 4.207

5.  Is preoperative serum lactate dehydrogenase useful in predicting the outcomes of patients with upper tract urothelial carcinoma?

Authors:  Ping Tan; Jie Chen; Nan Xie; Hang Xu; Jianzhong Ai; Huan Xu; Liangren Liu; Lu Yang; Qiang Wei
Journal:  Cancer Med       Date:  2018-08-27       Impact factor: 4.452

6.  The prognostic significance of Albumin-to-Alkaline Phosphatase Ratio in upper tract urothelial carcinoma.

Authors:  Ping Tan; Nan Xie; Jianzhong Ai; Hang Xu; Huan Xu; Liangren Liu; Lu Yang; Qiang Wei
Journal:  Sci Rep       Date:  2018-08-17       Impact factor: 4.379

Review 7.  Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring.

Authors:  D R Dufour; J A Lott; F S Nolte; D R Gretch; R S Koff; L B Seeff
Journal:  Clin Chem       Date:  2000-12       Impact factor: 8.327

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.